Evidence map›Paper›PMID 32555245›Full record

ArticleScientific reports2020

Roles of Elm1 in antifungal susceptibility and virulence in Candida glabrata.

Yuya Ito, Taiga Miyazaki, Yutaka Tanaka, Takashi Suematsu, Hironobu Nakayama, Akihiro Morita, Tatsuro Hirayama, Masato Tashiro, Takahiro Takazono, Tomomi Saijo and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Insights on molecular drivers of phenotypic plasticity in Candidozyma auris.World journal of microbiology & biotechnology · 2026
    Review
  3. Uridine diphosphateFEMS microbes · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Yuya ItoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Taiga MiyazakiDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan. taiga-m@nagasaki-u.ac.jp.
Yutaka TanakaDepartment of Infection and Host Defense, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Takashi SuematsuCentral Electron Microscope Laboratory, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hironobu NakayamaFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan.
Akihiro MoritaFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan.
Tatsuro HirayamaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Masato TashiroDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Takahiro TakazonoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Tomomi SaijoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Shintaro ShimamuraDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Kazuko YamamotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Yoshifumi ImamuraDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Koichi IzumikawaDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Shigeru KohnoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nagasaki University Hospital · JPNagasaki University · JPSuzuka University of Medical Science · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elm1 is a serine/threonine kinase involved in multiple cellular functions, including cytokinesis, morphogenesis, and drug resistance in Saccharomyces cerevisiae; however, its roles in pathogenic fungi have not been reported. In this study, we created ELM1-deletion, ELM1-reconstituted, ELM1-overexpression, and ELM1-kinase-dead strains in the clinically important fungal pathogen Candida glabrata and investigated the roles of Elm1 in cell morphology, stress response, and virulence. The elm1Δ strain showed elongated morphology and a thicker cell wall, with analyses of cell-wall components revealing that this strain exhibited significantly increased chitin content relative to that in the wild-type and ELM1-overexpression strains. Although the elm1Δ strain exhibited slower growth than the other two strains, as well as increased sensitivity to high temperature and cell-wall-damaging agents, it showed increased virulence in a Galleria mellonella-infection model. Moreover, loss of Elm1 resulted in increased adhesion to agar plates and epithelial cells, which represent important virulence factors in C. glabrata. Furthermore, RNA sequencing revealed that expression levels of 30 adhesion-like genes were elevated in the elm1Δ strain. Importantly, all these functions were mediated by the kinase activity of Elm1. To our knowledge, this is the first report describing the functional characterization of Elm1 in pathogenic fungi.

Indexed as

AnimalsAntifungal AgentsCandida glabrataCandidiasisCell AdhesionCell LineCell ProliferationCell WallFungal ProteinsGene Expression ProfilingGene Expression Regulation, FungalMiceMicrobial Sensitivity TestsMutagenesisPhenotypeProtein KinasesAntifungal AgentsELM1 protein, S cerevisiaeFungal ProteinsProtein KinasesSaccharomyces cerevisiae Proteins

Identifiers

PMID32555245
PMCPMC7299981
OpenAlexW3036419736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.